NASDAQ:SILKSilk Road Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Silk Road Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $50.59 +0.56 (+1.12 %) (As of 08/7/2020 10:52 AM ET) Add Compare Share Today's Range$50.00Now: $50.59▼$50.7850-Day Range$38.37MA: $44.26▼$50.0052-Week Range$20.84Now: $50.59▼$50.95Volume1,495 shsAverage Volume314,590 shsMarket Capitalization$1.59 billionP/E RatioN/ADividend YieldN/ABeta1.64 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.Read More Beat the Market (BTM) Rank™ 2.5 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $56.25, Silk Road Medical has a potential upside of 11.7% from its current price of $50.36.Amount of Analyst CoverageSilk Road Medical has only been the subject of 3 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesSilk Road Medical has received 68 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSilk Road Medical has received 67 “underperform” votes. (Add your “underperform” vote.)Community SentimentSilk Road Medical has received 50.37% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Silk Road Medical and other stocks. Vote “Outperform” if you believe SILK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SILK will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,427,760.00 in company stock.Percentage Held by InsidersOnly 7.80% of the stock of Silk Road Medical is held by insiders.Percentage Held by Institutions98.17% of the stock of Silk Road Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to grow in the coming year, from ($1.16) to ($0.69) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -39.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -39.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 21.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.33 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SILK Previous Symbol CUSIPN/A CIKN/A Webwww.silkroadmed.com Phone408-720-9002Debt Debt-to-Equity Ratio0.70 Current Ratio8.40 Quick Ratio7.56Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$63.35 million Price / Sales25.13 Cash FlowN/A Price / Cash FlowN/A Book Value$2.33 per share Price / Book21.71Profitability EPS (Most Recent Fiscal Year)($1.36) Net Income$-52,420,000.00 Net Margins-54.94% Return on Equity-44.17% Return on Assets-24.11%Miscellaneous Employees176 Outstanding Shares31,470,000Market Cap$1.59 billion Next Earnings Date11/3/2020 (Estimated) OptionableNot Optionable $50.59 +0.56 (+1.12 %) (As of 08/7/2020 10:52 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive SILK News and Ratings via Email Sign-up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter. Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions How has Silk Road Medical's stock been impacted by COVID-19 (Coronavirus)? Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SILK stock has increased by 36.2% and is now trading at $50.59. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Silk Road Medical? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Silk Road Medical. When is Silk Road Medical's next earnings date? Silk Road Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020. View our earnings forecast for Silk Road Medical. How were Silk Road Medical's earnings last quarter? Silk Road Medical Inc (NASDAQ:SILK) issued its quarterly earnings results on Wednesday, August, 5th. The company reported ($0.32) EPS for the quarter, beating analysts' consensus estimates of ($0.39) by $0.07. The business earned $15.10 million during the quarter, compared to analyst estimates of $12.37 million. Silk Road Medical had a negative net margin of 54.94% and a negative return on equity of 44.17%. The firm's quarterly revenue was up .7% compared to the same quarter last year. During the same period last year, the business earned ($0.42) earnings per share. View Silk Road Medical's earnings history. What price target have analysts set for SILK? 4 brokerages have issued 12 month target prices for Silk Road Medical's shares. Their forecasts range from $52.00 to $60.00. On average, they anticipate Silk Road Medical's share price to reach $56.25 in the next twelve months. This suggests a possible upside of 11.2% from the stock's current price. View analysts' price targets for Silk Road Medical. Has Silk Road Medical been receiving favorable news coverage? Press coverage about SILK stock has been trending positive this week, according to InfoTrie. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Silk Road Medical earned a news sentiment score of 2.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Silk Road Medical. Are investors shorting Silk Road Medical? Silk Road Medical saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 1,310,000 shares, a drop of 7.1% from the June 15th total of 1,410,000 shares. Based on an average trading volume of 514,400 shares, the short-interest ratio is presently 2.5 days. Currently, 4.3% of the shares of the company are sold short. View Silk Road Medical's Current Options Chain. Who are some of Silk Road Medical's key competitors? Some companies that are related to Silk Road Medical include Irhythm Technologies (IRTC), Globus Medical (GMED), Nevro (NVRO), Integra Lifesciences (IART), Haemonetics (HAE), ICU Medical (ICUI), Inovio Pharmaceuticals (INO), Inari Medical (NARI), Inspire Medical Systems (INSP), NuVasive (NUVA), Merit Medical Systems (MMSI), Cantel Medical (CMD), Glaukos (GKOS), AtriCure (ATRC) and Luminex (LMNX). View all competitors. What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Alibaba Group (BABA), Cisco Systems (CSCO), Home Depot (HD), Honeywell International (HON), Splunk (SPLK), Thermo Fisher Scientific (TMO), CVS Health (CVS), DexCom (DXCM), Raytheon Technologies (RTX) and Veeva Systems (VEEV). Who are Silk Road Medical's key executives? Silk Road Medical's management team includes the following people: Ms. Erica J. Rogers, Chief Exec. Officer, Pres & Director (Age 55)Mr. Lucas W. Buchanan, Chief Financial Officer (Age 41)Mr. Robert A. Nicholas, VP of Operations & Engineering (Age 56)Mr. Andrew S. Davis, Exec. VP of Global Sales & Marketing (Age 50)Ms. Alison Highlander, VP of HR When did Silk Road Medical IPO? (SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. What is Silk Road Medical's stock symbol? Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK." Who are Silk Road Medical's major shareholders? Silk Road Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Jennison Associates LLC (4.88%), Frontier Capital Management Co. LLC (1.66%), Peregrine Capital Management LLC (1.61%), Rhenman & Partners Asset Management AB (0.44%), GW&K Investment Management LLC (0.25%) and SG Americas Securities LLC (0.23%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and X Finance LP Wp. View institutional ownership trends for Silk Road Medical. Which major investors are selling Silk Road Medical stock? SILK stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Rhenman & Partners Asset Management AB, Chartwell Investment Partners LLC, Steward Partners Investment Advisory LLC, and Carroll Financial Associates Inc.. Company insiders that have sold Silk Road Medical company stock in the last year include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, and Richard Ruedy. View insider buying and selling activity for Silk Road Medical. Which major investors are buying Silk Road Medical stock? SILK stock was bought by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Jennison Associates LLC, GW&K Investment Management LLC, Mutual of America Capital Management LLC, SG Americas Securities LLC, Roubaix Capital LLC, Principal Financial Group Inc., and Swiss National Bank. View insider buying and selling activity for Silk Road Medical. How do I buy shares of Silk Road Medical? Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Silk Road Medical's stock price today? One share of SILK stock can currently be purchased for approximately $50.59. How big of a company is Silk Road Medical? Silk Road Medical has a market capitalization of $1.59 billion and generates $63.35 million in revenue each year. The company earns $-52,420,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis. Silk Road Medical employs 176 workers across the globe. What is Silk Road Medical's official website? The official website for Silk Road Medical is www.silkroadmed.com. How can I contact Silk Road Medical? Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected] This page was last updated on 8/7/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
